Clinical outcomes of EGFR kinase domain duplication to targeted therapies in NSCLC

Kinase domain duplications of the epidermal growth factor receptor (EGFR‐KDD) have been identified and implicated to be oncogenic in nonsmall cell lung cancers (NSCLCs). However, its prevalence and clinical contributions in lung cancer are largely unknown. Here, we conducted a multicenter record rev...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jinguang, Li, Xingya, Xue, Xingyang, Ou, Qiuxiang, Wu, Xue, Liang, Ying, Wang, Xiaonan, You, Ming, Shao, Yang W., Zhang, Zhihong, Zhang, Shucai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2018
Materias:
Cancer Genetics and Epigenetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590137/
https://www.ncbi.nlm.nih.gov/pubmed/30255937
http://dx.doi.org/10.1002/ijc.31895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590137/
https://www.ncbi.nlm.nih.gov/pubmed/30255937
http://dx.doi.org/10.1002/ijc.31895

Ejemplares similares